Floatz logo

Pbsc

Myeloproliferative Neoplasm

Fred Hutchinson Cancer CenterCell therapyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

79 Active assets in the Myeloproliferative Neoplasm cohort.

Asset / SponsorPhaseRating
Evomela
Center for International Blood and Marrow Transplant Research
Phase 2/3BBB
Fludarabine
Sawa Ito, MD
Phase 4BB
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2/3BB
Busulphan
Sawa Ito, MD
Phase 4BB
Romidepsin
Sawa Ito, MD
Phase 4BB

View all 50 →

Same molecule, other indications

Pbsc is also rated in:

Fanconi anemiaDormant
CCC
Indicative ·
53 / 100
View asset →
bone marrow failure syndromeDormant
CCC
Indicative ·
53 / 100
View asset →
chronic myelomonocytic leukemiaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →